Who are Solaris Pharma's investors?

Solaris Pharma's investors include Salvia.

How much funding has Solaris Pharma raised?

Solaris Pharma has disclosed $23.4M raised across 2 of its 3 known rounds.

Where is Solaris Pharma headquartered?

Solaris Pharma is headquartered in Bridgewater, US.

Solaris Pharma

Bridgewater, US · Founded 2014 · 1 known investors

Find your way into Solaris Pharma

8 people in our graph share verified history with the Solaris Pharma team — schools, employers, funds. One of them is your warm intro.

Shaishav Patelunlockedknows Kamlesh Amin · together at Sardar Patel University (overlapped)

×6knows the team · via Sardar Patel University

knows the team · via Emcure Pharmaceuticals USA, Inc

Solaris Pharma develops and supplies generic and specialty pharmaceutical products including topical, sterile, and tablet formulations. The company serves patients seeking high-quality, affordable therapeutic alternatives with an emphasis on regulatory compliance and manufacturing reliability.

Biotech Healthtech Medical Devices

Founders & leadership

Srinivasan Lakshmi RaghavanExecutive

Shalin JaniPresident & CEO

Kamlesh Amin Vice President, AR&DKamlesh Amin is Vice President of Analytical Research & Development at Solaris Pharma, where he leads work on generic and specialty pharmaceutical formulations. He has extensive experience in analytical method development and validation for pharmaceutical products, with expertise in spectroscopic and chromatographic techniques and knowledge of cGMP, GLP, and ICH regulatory guidelines.

Investors · 1

Salvialisted by SalviaHolzkirchen

Reported raises · per SEC filings

Form D private placements

$23.4M disclosed across 2 of 3 rounds · 2016–2019

▶$10MraisedJan 2020 · 6 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Bernhard HamplDirector
Srinivas Lakshmi RaghavanExecutive Officer, Director
Manish PottiDirector
Satish PejaverExecutive Officer, Director
Helmut JeggleDirector

Offering amount: $10M
Amount sold: $10M
First sale: Dec 2019
Incorporated: Corporation, New Jersey
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶Undisclosed amountofferedAug 2018 · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Srinivasan Lakshmi RaghavanDirector

Incorporated: Corporation, New Jersey, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$13.4MraisedNov 2016 · 6 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Srinivasan Lakshmi RaghavanExecutive Officer, Director

Offering amount: $13.4M
Amount sold: $13.4M
Minimum investment: $219K
Incorporated: Corporation, New Jersey, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

InvenInven provides AI-powered workflows for investment and consulting firms to automatically generate company materials such as market maps, financial profiles, and competitive landscapes from structured data. The platform serves management consulting firms and investment professionals who need to produce analyst-ready documents and decks at scale.

Companies working in the same space as Solaris Pharma.

Frequently asked questions

What does Solaris Pharma do?: Solaris Pharma develops and supplies generic and specialty pharmaceutical products including topical, sterile, and tablet formulations. The company serves patients seeking high-quality, affordable therapeutic alternatives with an emphasis on regulatory compliance and manufacturing reliability.
Who are Solaris Pharma's investors?: Solaris Pharma's investors include Salvia.
How much funding has Solaris Pharma raised?: Solaris Pharma has disclosed $23.4M raised across 2 of its 3 known rounds.
Where is Solaris Pharma headquartered?: Solaris Pharma is headquartered in Bridgewater, US.